Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
dc.contributor.author | Yilmaz, N. | |
dc.contributor.author | Emmungil, H. | |
dc.contributor.author | Gucenmez, S. | |
dc.contributor.author | Ozen, G. | |
dc.contributor.author | Yildiz, F. | |
dc.contributor.author | Balkarli, A. | |
dc.contributor.author | Kimyon, G. | |
dc.contributor.author | Coskun, B. N. | |
dc.contributor.author | Dogan, I. | |
dc.contributor.author | Pamuk, O. N. | |
dc.contributor.author | Yasar, S. | |
dc.contributor.author | Cetin, G. Yildirim | |
dc.contributor.author | Yazici, A. | |
dc.contributor.author | Esmen, S. Ergulu | |
dc.contributor.author | Cagatay, Y. | |
dc.contributor.author | Yilmaz, S. | |
dc.contributor.author | Celle, A. | |
dc.contributor.author | Cefle, A. | |
dc.contributor.author | Sayarhoglu, M. | |
dc.contributor.author | Kasifoglu, T. | |
dc.contributor.author | Karadag, O. | |
dc.contributor.author | Pehlivan, Y. | |
dc.contributor.author | Dalilic, E. | |
dc.contributor.author | Kisacik, B. | |
dc.contributor.author | Cobankara, V. | |
dc.contributor.author | Erken, E. | |
dc.contributor.author | Direskeneli, H. | |
dc.contributor.author | Aksu, K. | |
dc.contributor.author | Yavuz, S. | |
dc.date.accessioned | 2019-10-27T20:25:52Z | |
dc.date.available | 2019-10-27T20:25:52Z | |
dc.date.issued | 2015 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 11th International Congress on Systemic Lupus Erythematosus -- SEP 02-06, 2015 -- Vienna, AUSTRIA | en_US |
dc.identifier.endpage | S67 | en_US |
dc.identifier.issn | 0392-856X | |
dc.identifier.issn | 1593-098X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | S67 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/42275 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000360421900240 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Clinical & Exper Rheumatology | en_US |
dc.relation.ispartof | Clinical and Experimental Rheumatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide | en_US |
dc.type | Conference Object | en_US |